C

ChromaDex Corp
D

CDXC

7.60000
USD
0.16
(2.15%)
Market Closed
Volume
33,832
EPS
0
Div Yield
-
P/E
380
Market Cap
580,512,829
Related Instruments
    B
    BGI
    0.02000
    (1.09%)
    1.85000 USD
    J
    JAGX
    -0.08040
    (-7.73%)
    0.95960 USD
    L
    LYRA
    -0.01160
    (-6.38%)
    0.17010 USD
    S
    SNDL
    0.00500
    (0.26%)
    1.95500 USD
    V
    VBIV
    0
    (0%)
    0.000000 USD
    V
    VVOS
    -0.30000
    (-9.58%)
    2.83000 USD
    More
News

Title: ChromaDex Corp

Sector: Consumer Defensive
Industry: Packaged Foods
ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.